By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

resTORbio, Inc. 



Boston  Massachusetts    U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS

resTORbio, Inc., a subsidiary of PureTech Health (LSE: PRTC; www.puretechhealth.com), is developing medicines to treat aging-related diseases and conditions. resTORbio’s lead program is targeting the mechanistic target of rapamycin complex 1 (mTORC1) pathway to treat aging-related diseases and conditions with an initial focus on conditions caused by immunosenescence, the decline in immune function due to aging. resTORbio’s lead program is built upon two Phase 2 clinical studies demonstrating promising safety and efficacy results in almost 500 hundred elderly subjects. resTORbio is pursuing a pragmatic clinical development plan addressing areas of key unmet medical need in the aging population.

LEADERSHIP:

CEO: Chen Schor

CMO: Joan Mannick

FOLLOW RESTORBIO:



Key Statistics


Email:
Ownership: Subsidiary

Web Site: resTORbio, Inc.
Employees:
Symbol: 
 



Industry
Biotechnology






Company News
//-->